Anson Funds Management’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-327,110
Closed -$540K 147
2024
Q3
$540K Buy
+327,110
New +$540K 0.05% 104